A new study has found that antimalarial drug hydroxychloroquine is not effective at treating COVID-19 and may cause adverse effects, The Hill reported Thursday.
The study, published in the New England Journal of Medicine, found that hydroxychloroquine did not improve outcomes for the 667 COVID-19 patients participating in a randomized trial at 55 Brazilian hospitals.